Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Histogen stock
Learn how to easily invest in Histogen stock.
Histogen Inc is a biotechnology business based in the US. Histogen shares (HSTO) are listed on the NASDAQ and all prices are listed in US Dollars. Histogen employs 19 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Histogen
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – HSTO – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Histogen stock price (NASDAQ: HSTO)Use our graph to track the performance of HSTO stocks over time.
Histogen shares at a glance
|Latest market close||$0.27|
|52-week range||$0.26 - $1.98|
|50-day moving average||$0.45|
|200-day moving average||$0.79|
|Wall St. target price||$2.70|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.49|
Buy Histogen shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Histogen stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Histogen price performance over time
|1 week (2022-01-12)||-3.57%|
|1 month (2021-12-17)||-30.59%|
|3 months (2021-10-19)||-62.66%|
|6 months (2021-07-19)||-68.24%|
|1 year (2021-01-19)||-77.12%|
|2 years (2020-01-17)||-37.41%|
|3 years (2019-01-18)||1.85|
|5 years (2017-01-19)||4.54|
|Revenue TTM||$1.5 million|
|Gross profit TTM||$-5,022,000|
|Return on assets TTM||-47.67%|
|Return on equity TTM||-113.61%|
|Market capitalisation||$13.2 million|
TTM: trailing 12 months
Histogen share dividends
We're not expecting Histogen to pay a dividend over the next 12 months.
Have Histogen's shares ever split?
Histogen's shares were split on a 1:10 basis on 26 May 2020. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Histogen shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Histogen shares which in turn could have impacted Histogen's share price.
Histogen Inc. , a clinical-stage therapeutics company, focuses on developing therapeutics based upon the products of fibroblast cells grown under simulated embryonic conditions. It offers HST-001, a hair stimulating complex that is in Phase 1b/2a clinical trial for the treatment of androgenic alopecia (hair loss); HST-003, a human extracellular matrix, which is in Phase 1/2 clinical trial to treat articular cartilage defects in the knee; and Emricasan, an orally active pan-caspase inhibitor that is in Phase 1 clinical trial for the treatment of COVID-19. The company's pre-clinical programs include HST-004, a cell conditioned media (CCM) solution to treat spinal disc repair; and HST-002, a human-derived collagen and extracellular matrix dermal filler for the treatment of facial folds and wrinkles. Histogen Inc. was founded in 2007 and is headquartered in San Diego, California. .
Histogen in the news
Microsoft's $68.7 billion deal for Activision once again shows big tech's dominance over legacy media
Histogen Inc Shares Near 52-Week Low - Market Mover
Supreme Court vaccine mandate ruling won't bar companies from demanding Covid shots for workers — Biden vows to advocate for that
Frequently asked questionsWhat percentage of Histogen is owned by insiders or institutions?
Currently 5.875% of Histogen shares are held by insiders and 5.695% by institutions. How many people work for Histogen?
Latest data suggests 19 work at Histogen. When does the fiscal year end for Histogen?
Histogen's fiscal year ends in December. Where is Histogen based?
Histogen's address is: 10655 Sorrento Valley Road, San Diego, CA, United States, 92121 What is Histogen's ISIN number?
Histogen's international securities identification number is: US43358Y1038
More guides on Finder
Donut savings review
Donut earns up to 10% APY, but you must have an iOS device.
Covid test stocks
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Is Berkshire Hathaway the next $1 trillion stock?
Buffett’s Berkshire Hathaway may now be on its way to becoming the next trillion-dollar company.
How to buy Affinia Therapeutics (AFTX) stock when it goes public
Everything we know about the Affinia Therapeutics IPO, plus information on how to buy in.
How to buy Austin Gold (AUST) stock when it goes public
Everything we know about the Austin Gold IPO, plus information on how to buy in.
How to buy VinFast stock when it goes public
Everything we know about the VinFast IPO, plus information on how to buy in.
NFT-funded LinksDAO moves $10.5 million closer to buying a golf course
Creating a golf club is a thus-far unique application of NFTs, and another step forward for the decentralized economy.
How to buy Nexalin Technology (NXL) stock when it goes public
Everything we know about the Nexalin Technology IPO, plus information on how to buy in.
How to buy Specialty Building Products (SBP) stock when it goes public
Everything we know about the Specialty Building Products IPO, plus information on how to buy in.
How to buy HeartCore Enterprises (HTCR) stock when it goes public
Everything we know about the HeartCore Enterprises IPO, plus information on how to buy in.
Ask an Expert